Atara Biotherapeutics Announces Proposed Offering Of Common Stock

SOUTH SAN FRANCISCO, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) — Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced that it has commenced an underwritten public offering of $100,000,000 of its shares of common stock. In addition, Atara Biotherapeutics expects to…

Pension Dilemma: Expecting 7% Returns In A Negative Yield Setup

Wilshire Consulting predicts 6.25% return on US Equities over a decade. Hussman and GMO predict negative returns. Wilshire Consulting’s time horizon is 10 years, GMO’s is 7 years, and Hussman’s is 12 years. The feature image is from GMO’s Third-Quarter Report as of 10/31/2017. The report, which I highly recommend reading, states “*The chart represents local, real…

3 ETFs & Stocks To Play The January Effect

January is usually a pretty strong month for stocks, suggesting that many could see large gains to start the year if historical trends hold true yet again. This is largely attributed to the “January Effect.” What is January Effect? January Effect is a seasonal increase in stock prices due largely to year-end tax considerations. Investors…

The Surprising Outperformance Of A Value-Tilted Strategy In 2017

2017 was the year of growth over value—year-to-date through December 1st, the S&P 500 Growth Index outperformed the S&P 500 Value Index by essentially double the return, or a 1,300 basis point (bps) spread. Year-to-Date Total Returns of Value vs. Growth This performance advantage for growth investing largely stemmed from an over-weight in the Information Technology sector—approximately 800 bps of the differential was driven…

Tactical Trend, Q4 2017

Recognizing strengths and weaknesses among primary asset classes is the core goal of our Tactical Trend strategy. The strategy seeks to identify relative strength and trend strength in an attempt to allocate capital to the strongest asset classes while underweighting or eliminating exposure to the weaker asset classes. We perform rigorous surveillance on the following…

The 2018 Global Financial Asset Portfolio

The Global Financial Asset Portfolio¹ is a simple approximation of the world’s current financial asset allocation. It is, in my opinion, the logical starting point for anyone trying to build a diversified portfolio because it is the closest reflection of “the market portfolio”. In other words, if you were a true adherent of the Efficient…